The latest pharmaceutical and healthcare news from Pharma Journal: regulatory decisions, approvals, company announcements and the developments moving the industry, for professionals across pharma, biotech and clinical practice.
The primary endpoint data from the EVOKE and EVOKE Plus trials, presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference in late 2024 and subsequently reported in Nature Medicine (2025), show that semaglutide (Novo Nordisk; Ozempic at 1mg subcutaneous weekly)…
By Tom Okafor, Clinical Trials Correspondent
PCSK9 inhibitors reduce LDL-C by up to 60% on top of statins. Discover the mechanism, FOURIER and ODYSSEY OUTCOMES trial findings, and UK NICE access criteria.
By Tom Okafor, Clinical Trials Correspondent
The Janus kinase family comprises four intracellular tyrosine kinases JAK1, JAK2, JAK3, and TYK2 that transduce signals from a broad range of cytokine receptors to downstream transcription factors, principally the signal transducer and activator of transcription (STAT) proteins.…
By Dr. Eleanor Vance, Regulatory Affairs Editor
The MHRA has granted first-in-world approval for belantamab mafodotin combination regimens in relapsed myeloma, supported by landmark DREAMM-7 and DREAMM-8 Phase 3 trial data.
By Megan Liu, Digital Health Reporter
NHS England has widened abiraterone acetate access for adults with high-risk non-metastatic prostate cancer, with treatment expected to reach eligible patients within weeks. The change matters because
By Tom Okafor, Clinical Trials Correspondent
Chronic illness drives demand across the NHS and shapes budgets, workforce planning and service design. People living with multiple long-term conditions account for around half of hospital admissions,
By Dr. Eleanor Vance, Regulatory Affairs Editor
Antimicrobial resistance is accelerating across health systems and undermining routine care. Surgical prophylaxis, oncology regimens and neonatal medicine all depend on reliable antibiotics, yet resis
By Priya Raghavan, Biotech & Markets Analyst
Community pharmacy in the UK has entered a decisive phase. Policy, funding, and data infrastructure now point to a model where pharmacies act as clinical hubs for chronic disease management, preventio
By James Whitfield, Manufacturing & Supply Chain Writer
Isopropyl alcohol (IPA) remains a critical solvent and intermediate in various industries, including healthcare, personal care, and electronics. Analyst estimates diverge on headline size, yet all sig
By Dr. Eleanor Vance, Regulatory Affairs Editor
Nitazenes are highly potent synthetic opioids from the benzimidazole family that now present a fast-moving threat in the United Kingdom and in other regions. The core scaffold places them apart from n
By Dr. Eleanor Vance, Regulatory Affairs Editor
Molecular biology studies how DNA, RNA and proteins control the behaviour of cells. It asks how genetic information is stored, copied, transcribed and translated, then traces how those molecular instr
By Dr. Eleanor Vance, Regulatory Affairs Editor
The hot flush that wakes you at 03:00, the sudden fog that steals a board‑room sentence, the invisible shift that hollows bones – the menopausal transition is blunt. Yet for many, relief sits in plain
By Dr. Eleanor Vance, Regulatory Affairs Editor
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy